Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 PD-1 Inhibitor promising in treatment of triple-negative breast cancer.

Literature DB >> 26290901

PD-1 Inhibitor promising in treatment of triple-negative breast cancer.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2015 PMID： 26290901

Source DB: PubMed Journal: Hum Vaccin Immunother ISSN： 2164-5515 Impact factor: 3.452

Keyword Cloud
Cited

× No keyword cloud information.

2 in total

1. Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast Cancer.

Authors: Xuan Ge; Susan E Yost; Jin Sun Lee; Paul H Frankel; Christopher Ruel; Yujie Cui; Mireya Murga; Aileen Tang; Norma Martinez; Samuel Chung; Christina Yeon; Daphne Stewart; Daneng Li; Swapnil Rajurkar; George Somlo; Joanne Mortimer; James Waisman; Yuan Yuan
Journal: Cancers (Basel) Date: 2022-09-01 Impact factor: 6.575

2. Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer.

Authors: Yuan Yuan; Jin Sun Lee; Susan E Yost; Paul H Frankel; Christopher Ruel; Colt A Egelston; Weihua Guo; Simran Padam; Aileen Tang; Norma Martinez; Daniel Schmolze; Cary Presant; Behnam Ebrahimi; Christina Yeon; Mina Sedrak; Niki Patel; Jana Portnow; Peter Lee; Joanne Mortimer
Journal: Eur J Cancer Date: 2021-07-01 Impact factor: 10.002

2 in total